Search

everythinglearnresearchcommunity

for

Search:↓

Vav2 and Vav3 proteins help control skin stem cell numbers and activity in both healthy and cancerous cells.

The visfatin GT genotype may increase the risk of Alopecia Areata.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Multiphoton microscopy is a promising tool for detailed skin imaging and could improve patient care if its challenges are addressed.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Oral cyclosporin doesn't stop hair loss.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Green tea compound EGCG helps mink hair follicles grow by affecting certain cell growth pathways.

Psychotropic medications can cause skin problems, including serious conditions, and patients should be monitored closely.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Finasteride doesn't affect erections much, but may decrease libido in men.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Sinapic acid may help hair growth by activating a specific cell pathway.

Different cell types work together to repair skin, and targeting them may improve healing and reduce scarring.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Aging mice have slower hair regeneration due to changes in signal balance, but the environment, not stem cell loss, controls this, suggesting treatments could focus on environmental factors.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.